Development and characterization of naive single-type tumor antigen-specific CD8⁺ T lymphocytes from murine pluripotent stem cells

References

• Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 2015; 348:62-8; PMID:25838374; https://doi.org/10.1126/science.aaa4967
   PubMed Web of Science ®Google Scholar
• Antsiferova O, Muller A, Ramer PC, Chijioke O, Chatterjee B, Raykova A, Planas R, Sospedra M, Shumilov A, Tsai MH et al. Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice. PLoS Pathog 2014; 10:e1004333; PMID:25165855; https://doi.org/10.1371/journal.ppat.1004333
   PubMed Web of Science ®Google Scholar
• Klebanoff CA, Rosenberg SA, Restifo NP. Prospects for gene-engineered T cell immunotherapy for solid cancers. Nat Med 2016; 22:26-36; PMID:26735408; https://doi.org/10.1038/nm.4015
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26:101-6; PMID:18059259; https://doi.org/10.1038/nbt1374
   PubMed Web of Science ®Google Scholar
• Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den Boom D et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009; 136:411-9; PMID:19203577; https://doi.org/10.1016/j.cell.2009.01.023
   PubMed Web of Science ®Google Scholar
• Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009; 136:964-77; PMID:19269371; https://doi.org/10.1016/j.cell.2009.02.013
   PubMed Web of Science ®Google Scholar
• Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ, Consiglio A, Castellà M, Río P, Sleep E et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009; 460:53-9; PMID:19483674; https://doi.org/10.1038/nature08129
   PubMed Web of Science ®Google Scholar
• Li Z, Yang CS, Nakashima K, Rana TM. Small RNA-mediated regulation of iPS cell generation. EMBO J 2011; 30:823-34; PMID:21285944; https://doi.org/10.1038/emboj.2011.2
   PubMed Web of Science ®Google Scholar
• Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011; 474:212-5; PMID:21572395; https://doi.org/10.1038/nature10135
   PubMed Web of Science ®Google Scholar
• Lei F, Zhao B, Haque R, Xiong X, Budgeon L, Christensen ND, Wu Y, Song J. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance. Cancer Res 2011; 71:4742-7; PMID:21628492; https://doi.org/10.1158/0008-5472.CAN-11-0359
   PubMed Web of Science ®Google Scholar
• Haque R, Lei F, Xiong X, Bian Y, Zhao B, Wu Y, Song J. Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity. J Immunol 2012; 189:1228-36; PMID:22732595; https://doi.org/10.4049/jimmunol.1200633
   PubMed Web of Science ®Google Scholar
• Haque M, Song J, Fino K, Sandhu P, Wang Y, Ni B, Fang D, Song J. Melanoma immunotherapy in mice using genetically engineered pluripotent stem cells. Cell Transplant 2016; 25:811-27; PMID:26777320; https://doi.org/10.3727/096368916X690467
   PubMed Web of Science ®Google Scholar
• Haque M, Song J, Fino K, Sandhu P, Song X, Lei F, Zheng S, Ni B, Fang D, Song J. Stem cell-derived tissue-associated regulatory T cells ameliorate the development of autoimmunity. Sci Rep 2016; 6:20588; PMID:26846186; https://doi.org/10.1038/srep20588
   PubMed Web of Science ®Google Scholar
• Themeli M, Kloss CC, Ciriello G, Fedorov VD, Perna F, Gonen M, Sadelain M. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nat Biotechnol 2013; 31:928-33; PMID:23934177; https://doi.org/10.1038/nbt.2678
   PubMed Web of Science ®Google Scholar
• Nishimura T, Kaneko S, Kawana-Tachikawa A, Tajima Y, Goto H, Zhu D, Nakayama-Hosoya K, Iriguchi S, Uemura Y, Shimizu T et al. Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation. Cell Stem Cell 2013; 12:114-26; PMID:23290140; https://doi.org/10.1016/j.stem.2012.11.002
   PubMed Web of Science ®Google Scholar
• Haque R, Song J, Haque M, Lei F, Sandhu P, Ni B, Zheng S, Fang D, Yang JM, Song J. c-Myc-induced survivin is essential for promoting the notch-dependent T Cell differentiation from hematopoietic stem cells. Genes (Basel) 2017; 8:pii: E97; https://doi.org/10.3390/genes8030097
   Web of Science ®Google Scholar
• Klug F, Prakash H, Huber PE, Seibel T, Bender N, Halama N, Pfirschke C, Voss RH, Timke C, Umansky L et al. Low-dose irradiation programs macrophage differentiation to an iNOS(+)/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell 2013; 24:589-602; PMID:24209604; https://doi.org/10.1016/j.ccr.2013.09.014
   PubMed Web of Science ®Google Scholar
• Kwong B, Gai SA, Elkhader J, Wittrup KD, Irvine DJ. Localized immunotherapy via liposome-anchored Anti-CD137 + IL-2 prevents lethal toxicity and elicits local and systemic antitumor immunity. Cancer Res 2013; 73:1547-58; PMID:23436794; https://doi.org/10.1158/0008-5472.CAN-12-3343
   PubMed Web of Science ®Google Scholar
• Palucka AK, Coussens LM. The basis of oncoimmunology. Cell 2016; 164:1233-47; PMID:26967289; https://doi.org/10.1016/j.cell.2016.01.049
   PubMed Web of Science ®Google Scholar
• Khalil DN, Smith EL, Brentjens RJ, Wolchok JD. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. Nat Rev Clin Oncol 2016; 13:394; PMID:27118494; https://doi.org/10.1038/nrclinonc.2016.65
   PubMed Web of Science ®Google Scholar